Armata Pharmaceuticals, Inc. Share Price
ARMPArmata Pharmaceuticals, Inc. Stock Performance
Open $6.84 | Prev. Close $6.58 | Circuit Range N/A |
Day Range $6.58 - $6.84 | Year Range $0.91 - $16.34 | Volume 1,882 |
Average Traded $6.70 |
Armata Pharmaceuticals, Inc. Share Price Chart
About Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.
Armata Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Nov-25 | $6.84 | $6.69 | +0.00% |
12-Nov-25 | $6.84 | $6.69 | +4.37% |
11-Nov-25 | $6.26 | $6.41 | +4.57% |
10-Nov-25 | $6.45 | $6.13 | +6.52% |
07-Nov-25 | $5.64 | $5.75 | +1.32% |
06-Nov-25 | $5.60 | $5.68 | +1.16% |
05-Nov-25 | $5.00 | $5.62 | +15.30% |